new_adrs_0322_0738|IVBIY|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|price_next_month|price_second_month
new_adrs_0322_0738|IVBIY|1|Innovent Biologics Inc Total Current Assets (Quarterly) (USD)|Innovent Biologics Inc Cash and Short Term Investments (Quarterly) (USD)|Innovent Biologics Inc Inventories (Quarterly) (USD)|Innovent Biologics Inc Net PP&E (Quarterly) (USD)|Innovent Biologics Inc Goodwill and Intangibles (Quarterly) (USD)|Innovent Biologics Inc Total Liabilities (Quarterly) (USD)|Innovent Biologics Inc Total Current Liabilities (Quarterly) (USD)|Innovent Biologics Inc Total Long Term Liabilities (Quarterly) (USD)|Innovent Biologics Inc Total Deposits (Quarterly) (USD)|Innovent Biologics Inc Book Value (Quarterly) (USD)|Innovent Biologics Inc Retained Earnings (Quarterly) (USD)|Innovent Biologics Inc Treasury Stock (Quarterly) (USD)|Innovent Biologics Inc EV to Revenues|Innovent Biologics Inc EV to Earnings|Innovent Biologics Inc EV to Free Cash Flow|Innovent Biologics Inc EV to Assets (Quarterly)|Innovent Biologics Inc PS Ratio|Innovent Biologics Inc PE Ratio|Innovent Biologics Inc Price to Book Value|Innovent Biologics Inc PEG Ratio|Innovent Biologics Inc Debt to Equity Ratio|Innovent Biologics Inc Dividend Yield|Innovent Biologics Inc Shareholder Yield (TTM)|Innovent Biologics Inc Percent of Shares Outstanding Short|Innovent Biologics Inc Total Receivables (Quarterly) (USD)|Innovent Biologics Inc Total Payables (Quarterly) (USD)|Innovent Biologics Inc Total Capital Stock (Quarterly) (USD)|Innovent Biologics Inc Return on Invested Capital|Innovent Biologics Inc Quality Ratio Score|Innovent Biologics Inc Momentum Score|Innovent Biologics Inc Beta (1Y)|Innovent Biologics Inc Sustainable Growth Rate (TTM)|Innovent Biologics Inc Institutional Investor Ownership Percentage|Innovent Biologics Inc Average Diluted Shares Outstanding (Quarterly)|Innovent Biologics Inc Total Employees (Annual)|Innovent Biologics Inc EPS Diluted (Quarterly) (USD)|Innovent Biologics Inc Shares Outstanding|Innovent Biologics Inc Repurchase of Capital Stock (Quarterly) (USD)|Innovent Biologics Inc Ordinary Shares Number (Quarterly)|Innovent Biologics Inc Payout Ratio|Innovent Biologics Inc Quick Ratio (Quarterly)|Innovent Biologics Inc Normalized Diluted EPS (Quarterly) (USD)|Innovent Biologics Inc Stock Buybacks (Quarterly) (USD)|Innovent Biologics Inc Effective Tax Rate (TTM)|Innovent Biologics Inc Return on Equity|Innovent Biologics Inc Net Income (TTM) (USD)|Innovent Biologics Inc Revenue (TTM) (USD)|Innovent Biologics Inc Dividend Per Share (Quarterly) (USD)|Innovent Biologics Inc Revenue (Quarterly) (USD)|Innovent Biologics Inc Gross Profit (Quarterly) (USD)|Innovent Biologics Inc SG&A Expense (Quarterly) (USD)|Innovent Biologics Inc Pre-Tax Income (Quarterly) (USD)|Innovent Biologics Inc Net Income (Quarterly) (USD)|Innovent Biologics Inc Net Interest Income (Quarterly) (USD)|Innovent Biologics Inc Price (USD)|Innovent Biologics Inc Total Return Price (USD)|Innovent Biologics Inc Enterprise Value (USD)|Innovent Biologics Inc 30-Day Average Daily Volume|Innovent Biologics Inc 1 Year Price Returns (Daily)||
new_adrs_0322_0738|IVBIY|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric||
new_adrs_0322_0738|IVBIY|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily||
new_adrs_0322_0738|IVBIY|5|182.428571429|182.428571429|182.428571429|182.428571429|182.428571429|182.428571429|182.428571429|182.428571429||182.428571429|||||||||3.15269461078|||1.45844875346|||182.428571429|182.428571429|182.428571429||||30.4090909091||30.4615384615||164.333333333||74.8461538462||182.428571429|||||||91.2857142857|||||91.2||91.2||1.45844875346|1.45844875346|4.99052132701|1.45021645022|1.44936708861||
new_adrs_0322_0738|IVBIY|6|7|7|7|7|7|7|7|7||7|||||||||334|||722|||7|7|7||||22||13||6||13||7|||||||7|||||10||10||722|722|211|693|474||
new_adrs_0322_0738|IVBIY|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily||
new_adrs_0322_0738|IVBIY|201712|221.4463|202.1775|8.8413|125.8809|8.285|624.8331|25.009|599.8241||-297.5401|||||||||||||||2.0016|11.154|0.0012||||||||||||1118.1507||||||||||||||||||||||
new_adrs_0322_0738|IVBIY|201806|578.978|312.0779|7.3896|133.2093|8.0664|975.7742|267.0674|708.7068||-237.4505|||||||||||||||2.5301|243.5131|0.0021||||||||||||1118.1507||||||||||||||||||||||
new_adrs_0322_0738|IVBIY|201809|||||||||||||||||||||||||||||||||||777||279.5377||||||||||||||||||||||||
new_adrs_0322_0738|IVBIY|201812|681.2418|657.778|9.612|163.2748|7.6816|278.8434|97.4446|181.3988||609.742|||||||||||||||3.0863|25.0646|0.0115||||||||959||288.4007||1153.6027||||||||||||-1204||-304||||||||
new_adrs_0322_0738|IVBIY|201903|||||||||||||||||||6.1488||||||||||||||||||||||||||||||||-1780||-176||13|13|3206.5641|||13|
new_adrs_0322_0738|IVBIY|201906|587.9539|505.9555|33.6256|189.5269||301.5171|97.7868|203.7303||512.3411|||||||||6.1488||||||28.1007|33.0224|0.0115||||||||1445||289.2494||1156.9977||||||||||||-1969||-208||13|13|3206.5641|||13|13
new_adrs_0322_0738|IVBIY|201909|||||||||||||||||||7.3393||||||||||||||||||314.3292|||||||||-956|||||-2048||-268||13|13|3370.7371|||13|13
new_adrs_0322_0738|IVBIY|201912|779.7|671.0418|51.2514|217.4062||353.6459|149.1471|204.4988||679.7558|||||||||7.9757||||||35.7361|48.7367|0.0124||||||||1982||315.6406||1262.5622|||||||-920|||||-4027||-268||13|13|3696.7745|||13|13
new_adrs_0322_0738|IVBIY|202003|||||||||||||||||||6.4184||||||||||||||||||335.6783|||||||||-873|||||-10408||-129||13|13|3809.8092|||13|13
new_adrs_0322_0738|IVBIY|202006|1010.0661|873.5468|65.8765|215.9113|4.965|359.5535|152.9927|206.5608||903.1846|||||||||4.8331||||||53.5919|55.5672|0.0131||||||||2673||335.7814||1343.1257|||||||-680|||||-3066||-15||13|13|3624.031|||13|13
new_adrs_0322_0738|IVBIY|202009|||||||||||||||||||5.0368||||||||||||||0.1496||||350.1995|||||||||-430|||||1847||-18||13|13|3808.0005|||13|13
new_adrs_0322_0738|IVBIY|202012|1448.9891|1231.8629|108.0094|334.208|4.9936|467.639|227.4273|240.2117||1343.8492|||||||||5.0406||||||72.7623|68.0558|0.0148||||||0.143||3200||350.694||1402.776|||||||-197|||||1761||-35||13|13|3811.4663|||13|13
new_adrs_0322_0738|IVBIY|202103|||||||||||||||||||3.5203||||||||||||||0.0085|||||||||||||-215|||||-1102||-147||13|13|3679.4801|||13|13
new_adrs_0322_0738|IVBIY|202106|2077.7024|1652.5743|170.3978|421.2695|14.9904|703.9742|346.7453|357.2289||1841.4806|||||||||2.574||||||155.0567|138.4075|0.0155||||||0.0145||4500||364.6132||1458.453|||||||-520|||||-579||-320||13|13|3371.7146|||13|13
new_adrs_0322_0738|IVBIY|202109|||||||||||||||||||2.574||||||||||||||0.2242||||||||||||||||||||||13|13|3371.7146|||13|13
new_adrs_0322_0738|IVBIY|202112|||||||||||||||||||2.574||||||||||||||0.0041||||||||||||||||||||||13|13|3371.7146|||13|13
new_adrs_0322_0738|IVBIY|202203|||||||||||||||||||2.574||||||||||||||||||||||||||||||||||||13|13|3371.7146||||